C5orf22

gene
On this page

Also known as FLJ11193

Summary

C5orf22 (chromosome 5 open reading frame 22, HGNC:25639) is a protein-coding gene on chromosome 5p13.3, encoding UPF0489 protein C5orf22 (Q49AR2).

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 20 total — 1 pathogenic
  • MANE Select transcript: NM_018356

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25639
Approved symbolC5orf22
Namechromosome 5 open reading frame 22
Location5p13.3
Locus typegene with protein product
StatusApproved
AliasesFLJ11193
Ensembl geneENSG00000082213
Ensembl biotypeprotein_coding
Entrez55322

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 4 nonsense_mediated_decay, 3 protein_coding, 2 protein_coding_CDS_not_defined, 2 retained_intron

ENST00000325366, ENST00000504464, ENST00000504866, ENST00000507818, ENST00000510530, ENST00000510659, ENST00000511208, ENST00000513967, ENST00000515409, ENST00000517780, ENST00000926221

RefSeq mRNA: 1 — MANE Select: NM_018356 NM_018356

CCDS: CCDS3895

Canonical transcript exons

ENST00000325366 — 9 exons

ExonStartEnd
ENSE000018440743155277331555053
ENSE000035254213153826031538689
ENSE000035557353155129331551432
ENSE000036437183154128131541402
ENSE000036442593153230131532473
ENSE000036494583154094931541011
ENSE000036675863154564631545712
ENSE000036914453153427231534417
ENSE000037867523153574431535893

Expression profiles

Bgee: expression breadth ubiquitous, 287 present calls, max score 98.08.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.9827 / max 239.3115, expressed in 1813 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
5596418.95761813
559650.02517

Top tissues by expression

294 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
secondary oocyteCL:000065598.08gold quality
oocyteCL:000002394.61gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450291.13gold quality
biceps brachiiUBERON:000150790.86gold quality
hair follicleUBERON:000207389.28silver quality
mucosa of sigmoid colonUBERON:000499389.16gold quality
epithelium of nasopharynxUBERON:000195189.03gold quality
colonic mucosaUBERON:000031788.84gold quality
skeletal muscle tissueUBERON:000113487.91gold quality
calcaneal tendonUBERON:000370187.59gold quality
gastrocnemiusUBERON:000138887.03gold quality
muscle of legUBERON:000138387.01gold quality
choroid plexus epitheliumUBERON:000391186.93gold quality
palpebral conjunctivaUBERON:000181286.92gold quality
muscle organUBERON:000163086.91gold quality
muscle tissueUBERON:000238586.84gold quality
heart right ventricleUBERON:000208086.75gold quality
deltoidUBERON:000147686.56gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451186.46gold quality
vastus lateralisUBERON:000137986.26silver quality
bone marrow cellCL:000209286.05gold quality
hindlimb stylopod muscleUBERON:000425285.69gold quality
tibialis anteriorUBERON:000138585.66gold quality
myocardiumUBERON:000234985.62gold quality
lateral nuclear group of thalamusUBERON:000273685.52gold quality
adrenal tissueUBERON:001830385.47gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099185.36gold quality
embryoUBERON:000092285.34gold quality
bone marrowUBERON:000237185.28gold quality
CA1 field of hippocampusUBERON:000388185.27gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.93

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): E2F4

miRNA regulators (miRDB)

129 targeting C5orf22, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-3163100.0077.238605
HSA-MIR-3646100.0073.565283
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-3667-3P99.9967.171636
HSA-MIR-607799.9968.042299
HSA-MIR-428299.9975.366408
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-433-3P99.9869.371203
HSA-MIR-548N99.9871.944170
HSA-MIR-1213699.9872.815713
HSA-MIR-548P99.9872.253784
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-512-3P99.9767.351049
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-590-3P99.9674.346478
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-548AT-5P99.9670.832666
HSA-MIR-548AA99.9670.643753
HSA-MIR-548AP-3P99.9670.643753
HSA-MIR-548T-3P99.9670.643753
HSA-MIR-96-5P99.9572.802140
HSA-LET-7C-3P99.9573.422862
HSA-MIR-545-3P99.9570.742783
HSA-MIR-55999.9572.283609
HSA-MIR-548AB99.9571.313488
HSA-MIR-548A-5P99.9471.273482
HSA-MIR-548AD-5P99.9471.233502
HSA-MIR-548AE-5P99.9471.233502

Literature-anchored findings (GeneRIF, showing 1)

  • A Proteomic Connectivity Map for Characterizing the Tumor Adaptive Response to Small Molecule Chemical Perturbagens. (PMID:31846293)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioC2H5orf22ENSDARG00000011723
mus_musculus6030458C11RikENSMUSG00000022195
rattus_norvegicusC2h5orf22ENSRNOG00000022745
drosophila_melanogasterMESR6FBGN0036846

Protein

Protein identifiers

UPF0489 protein C5orf22Q49AR2 (reviewed: Q49AR2)

All UniProt accessions (4): Q49AR2, B4DR92, E5RFG1, E5RHP8

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the UPF0489 family.

Isoforms (3)

UniProt IDNamesCanonical?
Q49AR2-11yes
Q49AR2-22
Q49AR2-33

RefSeq proteins (1): NP_060826* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR024131FlmR/OhkR-likeFamily

Pfam: PF12640

UniProt features (9 total): splice variant 3, sequence variant 2, chain 1, region of interest 1, compositionally biased region 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q49AR2-F185.160.75

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 110 (showing top): RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN, RYTTCCTG_ETS2_B, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, BIDUS_METASTASIS_UP, MARSON_BOUND_BY_E2F4_UNSTIMULATED, BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP, BROWNE_HCMV_INFECTION_48HR_UP, STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP, JOHNSTONE_PARVB_TARGETS_3_DN, TERAO_AOX4_TARGETS_SKIN_DN, PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN, LIM_MAMMARY_STEM_CELL_DN

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1

Protein interactions and networks

STRING

1000 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
C5orf22SAYSD1Q9NPB0580
C5orf22TPGS2Q68CL5562
C5orf22TRMT13Q9NUP7541
C5orf22RGS3P49796537
C5orf22TRPM6Q9BX84455
C5orf22PRR3P79522448
C5orf22PIGHQ14442437
C5orf22BDNFP23560429
C5orf22NXT2Q9NPJ8424
C5orf22TMEM267Q0VDI3397
C5orf22SPANXN1Q5VSR9397
C5orf22SPRYD7Q5W111370
C5orf22IFFO1Q0D2I5368
C5orf22ZNF250P15622366
C5orf22SPRING1Q9H741350

IntAct

33 interactions, top by confidence:

ABTypeScore
C5orf22WBP11psi-mi:“MI:0915”(physical association)0.800
WBP11PQBP1psi-mi:“MI:0914”(association)0.800
SURF2RPL5psi-mi:“MI:0914”(association)0.800
WBP11C5orf22psi-mi:“MI:0915”(physical association)0.800
OSMIL6STpsi-mi:“MI:0914”(association)0.760
ELOF1C5orf22psi-mi:“MI:0915”(physical association)0.670
C5orf22ELOF1psi-mi:“MI:0915”(physical association)0.670
C5orf22DDIT4Lpsi-mi:“MI:0915”(physical association)0.560
XAGE1ATHAP12psi-mi:“MI:0914”(association)0.530
SURF2HEXIM1psi-mi:“MI:0914”(association)0.530
NOL9IPO5psi-mi:“MI:0914”(association)0.530
SURF2KPNA6psi-mi:“MI:0914”(association)0.350
DEF8DPYSL4psi-mi:“MI:0914”(association)0.350
WBP11PQBP1psi-mi:“MI:0914”(association)0.350
CDC14BPPP1R12Apsi-mi:“MI:0914”(association)0.350
SPON1AHCYL1psi-mi:“MI:0914”(association)0.350
CTAG2PCNTpsi-mi:“MI:0914”(association)0.350
NOBOXCDK2psi-mi:“MI:0914”(association)0.350
FOXE3C1QBPpsi-mi:“MI:0914”(association)0.350
PQBP1ANK3psi-mi:“MI:0914”(association)0.350
PQBP1C5orf22psi-mi:“MI:0914”(association)0.350
C5orf22ELOF1psi-mi:“MI:0915”(physical association)0.000
C5orf22DDIT4Lpsi-mi:“MI:0915”(physical association)0.000
C5orf22WBP11psi-mi:“MI:0915”(physical association)0.000

BioGRID (40): C5orf22 (Affinity Capture-MS), C5orf22 (Affinity Capture-MS), ELOF1 (Two-hybrid), C5orf22 (Two-hybrid), C5orf22 (Affinity Capture-MS), C5orf22 (Affinity Capture-MS), C5orf22 (Affinity Capture-MS), C5orf22 (Affinity Capture-MS), C5orf22 (Affinity Capture-MS), C5orf22 (Negative Genetic), C5orf22 (Synthetic Lethality), C5orf22 (Affinity Capture-MS), WBP11 (Two-hybrid), ELOF1 (Two-hybrid), DDIT4L (Two-hybrid)

ESM2 similar proteins: A2AUU0, A3KMI0, E7F654, F1MAB7, P33279, P59114, Q08DH3, Q0P5B2, Q13686, Q28H30, Q3T131, Q3T9Z9, Q49AR2, Q4R8E0, Q5R5W9, Q5R6T6, Q5U2S3, Q5ZLL7, Q62240, Q63185, Q6DTM3, Q6NXH8, Q6NZP1, Q6P1Q9, Q6PAE6, Q6PD74, Q6ZUJ8, Q7SZF1, Q7TNN8, Q7Z3E5, Q8BGC1, Q8BMD7, Q8BMK1, Q8CHK4, Q8K3E5, Q8N6Q8, Q8TE76, Q8W5R2, Q92993, Q96IZ6

Diamond homologs: Q28H30, Q49AR2, Q5R5W9, Q6PAE6, Q7SZF1, Q8BGC1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

20 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance5
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
147643GRCh38/hg38 5p13.3(chr5:31208753-32173244)x3Pathogenic

SpliceAI

1623 predictions. Top by Δscore:

VariantEffectΔscore
5:31534269:CAGGT:Cacceptor_loss1.0000
5:31534270:A:AGacceptor_gain1.0000
5:31534270:A:Cacceptor_loss1.0000
5:31534271:G:GGacceptor_gain1.0000
5:31534271:GGTT:Gacceptor_gain1.0000
5:31534321:GTAAT:Gdonor_gain1.0000
5:31534326:G:GGdonor_gain1.0000
5:31535069:G:GTdonor_gain1.0000
5:31535070:A:Tdonor_gain1.0000
5:31535742:A:AGacceptor_gain1.0000
5:31535743:G:GGacceptor_gain1.0000
5:31535743:GA:Gacceptor_gain1.0000
5:31535743:GAGA:Gacceptor_gain1.0000
5:31535890:TCAG:Tdonor_loss1.0000
5:31535891:CAG:Cdonor_loss1.0000
5:31535892:AGG:Adonor_loss1.0000
5:31535893:GGT:Gdonor_loss1.0000
5:31535894:GT:Gdonor_loss1.0000
5:31535895:T:Adonor_loss1.0000
5:31538258:AG:Aacceptor_gain1.0000
5:31538259:GG:Gacceptor_gain1.0000
5:31538617:G:Tdonor_gain1.0000
5:31541008:AGAGG:Adonor_loss1.0000
5:31541009:GAG:Gdonor_gain1.0000
5:31541009:GAGG:Gdonor_loss1.0000
5:31541011:GGTAT:Gdonor_loss1.0000
5:31541012:G:GAdonor_loss1.0000
5:31541013:T:Adonor_loss1.0000
5:31541401:GG:Gdonor_gain1.0000
5:31541402:GG:Gdonor_gain1.0000

AlphaMissense

2918 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
5:31535763:T:AW83R0.998
5:31535763:T:CW83R0.998
5:31538646:A:TD255V0.998
5:31535823:T:AW103R0.997
5:31535823:T:CW103R0.997
5:31538646:A:CD255A0.997
5:31538647:T:AD255E0.997
5:31538647:T:GD255E0.997
5:31551306:G:AG358D0.997
5:31534345:A:TD52V0.996
5:31534360:T:CL57P0.996
5:31535808:T:AW98R0.996
5:31535808:T:CW98R0.996
5:31538665:T:AN261K0.996
5:31538665:T:GN261K0.996
5:31538669:T:CF263L0.996
5:31538671:C:AF263L0.996
5:31538671:C:GF263L0.996
5:31552794:T:GC407W0.996
5:31534338:C:GH50D0.995
5:31534350:C:GH54D0.995
5:31534357:A:TD56V0.995
5:31535762:T:AN82K0.995
5:31535762:T:GN82K0.995
5:31538646:A:GD255G0.995
5:31551294:T:AV354D0.995
5:31551302:G:CA357P0.995
5:31551303:C:AA357D0.995
5:31534346:C:AD52E0.994
5:31534346:C:GD52E0.994

dbSNP variants (sampled 300 via entrez): RS1000130906 (5:31549779 G>A), RS1000210208 (5:31543126 C>A), RS1000267384 (5:31549392 C>G), RS1000448397 (5:31551332 C>T), RS1000660907 (5:31543477 G>A), RS1000946695 (5:31543902 T>C), RS1000986523 (5:31538075 G>A), RS1001039103 (5:31537563 C>G,T), RS1001053777 (5:31550608 C>A), RS1001147591 (5:31544511 A>G), RS1001515570 (5:31544378 T>C), RS1001770571 (5:31530419 A>T), RS1001921965 (5:31549921 A>T), RS1002011016 (5:31555323 A>C,G), RS1002108861 (5:31543009 GA>G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST006991_2Cerebrospinal fluid t-tau levels in Alzheimer’s disease dementia9.000000e-07

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004760t-tau measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs10035440C5orf220.000

CTD chemical–gene interactions

22 total (human), top 22 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Aciddecreases expression, increases expression2
TAK-243increases sumoylation1
geldanamycinincreases expression1
triphenyl phosphateaffects expression1
glycidyl methacrylatedecreases expression1
trichostatin Adecreases expression1
beta-lapachoneincreases expression1
potassium chromate(VI)increases expression1
di-n-butylphosphoric acidaffects expression1
Resveratrolaffects cotreatment, increases expression1
Leflunomideincreases expression1
Air Pollutantsincreases abundance, increases expression1
Caffeinedecreases phosphorylation1
Doxorubicindecreases expression1
Etoposideaffects response to substance1
Methyl Methanesulfonateincreases expression1
Plant Extractsaffects cotreatment, increases expression1
Tobacco Smoke Pollutionincreases expression1
Tretinoindecreases expression1
Cyclosporineincreases expression1
Aflatoxin B1decreases methylation1
Particulate Matterincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.